{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:28:51Z","timestamp":1790141331991,"version":"4.0.1"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["21 (0859)\/11\/EMR-II"],"award-info":[{"award-number":["21 (0859)\/11\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.biopha.2017.04.030","type":"journal-article","created":{"date-parts":[[2017,4,15]],"date-time":"2017-04-15T20:31:30Z","timestamp":1492288290000},"page":"760-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"special_numbering":"C","title":["Antibacterial, antifungal and antimycobacterial compounds from cyanobacteria"],"prefix":"10.1016","volume":"90","author":[{"given":"Shasank S.","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir K.","family":"Paidesetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabindra N.","family":"Padhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.04.030_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.biopha.2017.04.030_bib0010","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2017.04.030_bib0015","series-title":"Worldwide Country Situation Analysis: Response to Antimicrobial Resistance","author":"World Health Organization (WHO)","year":"2017"},{"key":"10.1016\/j.biopha.2017.04.030_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-0711-12-17","article-title":"Multidrug-resistant bacterial isolates in infected wounds at Jimma University Specialized Hospital, Ethiopia","volume":"12","author":"Godebo","year":"2013","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.biopha.2017.04.030_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jksus.2015.05.007","article-title":"In vitro antibacterial activity of crude extracts of 9 selected medicinal plants against UTI causing MDR bacteria","volume":"29","author":"Mishra","year":"2017","journal-title":"J. King Saud. Univ. Sci."},{"key":"10.1016\/j.biopha.2017.04.030_bib0030","series-title":"Principles and Practice of Clinical Bacteriology","author":"Gillespie","year":"2006"},{"key":"10.1016\/j.biopha.2017.04.030_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.mib.2012.07.007","article-title":"Antimicrobials as promoters of genetic variation","volume":"15","author":"Bl\u00e1zquez","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0040","first-page":"365","article-title":"Multi drug resistant Shigella species in Nepal, a retrospective study conducted at national public health laboratory (NPHL), 1999 to 2002","volume":"4","author":"Shrestha","year":"2002","journal-title":"J. Nepal Health Res. Counc."},{"key":"10.1016\/j.biopha.2017.04.030_bib0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2017.04.030_bib0050","series-title":"The Burden of Health Care-Associated Infection Worldwide","author":"World Health Organization","year":"2011"},{"issue":"1246","key":"10.1016\/j.biopha.2017.04.030_bib0055","article-title":"Identification of Weissella species by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"6","author":"Lee","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2017.04.030_bib0065","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/AAC.00692-10","article-title":"Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria Denmark, and Spain","volume":"54","author":"Mortensen","year":"2010","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.biopha.2017.04.030_bib0070","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2017.04.030_bib0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1469-0691.12513","article-title":"Update on antifungal resistance in Aspergillus and Candida","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.biopha.2017.04.030_bib0080","series-title":"Global Tuberculosis Report","author":"World Health Organization (WHO)","year":"2016"},{"key":"10.1016\/j.biopha.2017.04.030_bib0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10389-012-0514-y","article-title":"Status of multidrug resistance in tubercle bacillus and phytochemicals for the control","volume":"21","author":"Dubey","year":"2013","journal-title":"J. Publ. Health"},{"key":"10.1016\/j.biopha.2017.04.030_bib0090","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","article-title":"A medicinal chemist's guide to molecular interactions","volume":"53","author":"Bissantz","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0095","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1016\/j.bmcl.2014.10.046","article-title":"Synthesis and biological evaluation of novel biaryl type \u03b1-noscapine congeners","volume":"24","author":"Manchukonda","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopha.2017.01.036","article-title":"Antibacterial activity, computational analysis and host toxicity study of thymol-sulfonamide conjugates","volume":"88","author":"Swain","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"4721","key":"10.1016\/j.biopha.2017.04.030_bib0105","article-title":"Chemical modulation of the biological activity of reutericyclin: a membrane-active antibiotic from Lactobacillus reuteri","volume":"4","author":"Cherian","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2017.04.030_bib0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1039\/C4NP00144C","article-title":"Marine natural products","volume":"32","author":"Blunt","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biopha.2017.04.030_bib0115","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2174\/138920112804724828","article-title":"The potential of microalgae for the production of bioactive molecules of pharmaceutical interest","volume":"13","author":"Mimouni","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0120","doi-asserted-by":"crossref","DOI":"10.1007\/s10811-017-1079-5","article-title":"Microalgal food supplements from the perspective of Polish consumers: patterns of use, adverse events, and beneficial effects","author":"Rzymski","year":"2017","journal-title":"J. Appl. Phycol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10482-015-0487-2","article-title":"Anticancer compounds from cyanobacterium Lyngbya species: a review","volume":"108","author":"Swain","year":"2015","journal-title":"Antonie Van Leeuwenh."},{"key":"10.1016\/j.biopha.2017.04.030_bib0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1462-2920.2001.00159.x","article-title":"Long-term compositional changes after transplant in a microbial mat cyanobacterial community revealed using a polyphasic approach","volume":"3","author":"Abed","year":"2001","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0135","first-page":"47","article-title":"Cyanobacterial biodiversity and application in biotechnology","volume":"89","author":"Thajuddin","year":"2005","journal-title":"Curr. Sci."},{"key":"10.1016\/j.biopha.2017.04.030_bib0140","first-page":"721","article-title":"Bergey\u2019s Manual of Systematic Bacteriology","author":"Boone","year":"2017"},{"key":"10.1016\/j.biopha.2017.04.030_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-8137.1995.tb03051.x","article-title":"Physiological ecology of cyanobacteria in microbial mass and other communities","volume":"131","author":"Stal","year":"1995","journal-title":"New Phytol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0150","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/aem.51.2.398-407.1986","article-title":"Adaptation to hydrogen sulfide of oxygenic and anoxygenic photosynthesis among cyanobacteria","volume":"51","author":"Cohen","year":"1986","journal-title":"Appl. Environ. Microb."},{"key":"10.1016\/j.biopha.2017.04.030_bib0155","doi-asserted-by":"crossref","DOI":"10.1029\/2004GB002331","article-title":"Nitrogen fixation by Trichodesmium spp.: An important source of new nitrogen to the tropical and subtropical North Atlantic ocean","volume":"19","author":"Capone","year":"2005","journal-title":"Glob. Biogeochem. Cy."},{"key":"10.1016\/j.biopha.2017.04.030_bib0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3177\/jnsv.36.165","article-title":"Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats","volume":"36","author":"Iwata","year":"1990","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.biopha.2017.04.030_bib0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/md14040081","article-title":"Antibacterial derivatives of marine algae: an overview of pharmacological mechanisms and applications","volume":"14","author":"Shannon","year":"2016","journal-title":"Mar. Drug"},{"key":"10.1016\/j.biopha.2017.04.030_bib0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ja.2011.21","article-title":"Antibacterial derivatives of marine algae: an overview of pharmacological mechanisms and applications","volume":"64","author":"Singh","year":"2011","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.biopha.2017.04.030_bib0175","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1021\/jm060327w","article-title":"sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity","volume":"49","author":"Muller","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0180","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/np800751j","article-title":"Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua","volume":"72","author":"Mo","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0185","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.phytochem.2011.07.014","article-title":"antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam","volume":"72","author":"Montaser","year":"2011","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2017.04.030_bib0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11418-008-0238-z","article-title":"Two new antibacterial norabietane diterpenoids from cyanobacteria, Microcoleous lacustris","volume":"62","author":"P\u00e9rez Guti\u00e9rrez","year":"2008","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.biopha.2017.04.030_bib0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2006-958092","article-title":"Biological activities of cyanobacteria: evaluation of extracts and pure compounds","volume":"61","author":"Falch","year":"1995","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2017.04.030_bib0200","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/np060495r","article-title":"Antimicrobial ambiguines from the cyanobacterium Fischerella sp. collected in Israel","volume":"70","author":"Raveh","year":"2007","journal-title":"J. Nat. Prod."},{"issue":"May","key":"10.1016\/j.biopha.2017.04.030_bib0205","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/np800751j","article-title":"Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua","volume":"72","author":"Mo","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0210","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1021\/jo00226a009","article-title":"Fontonamide and anhydrohapaloxindole A, two new alkaloids from the blue-green alga Hapalosiphon fontinalis","volume":"52","author":"Moore","year":"1987","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0215","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/np50105a018","article-title":"Beta-carbolines from the blue-green alga Dichothrix baueriana","volume":"57","author":"Larsen","year":"1994","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1134\/S0003683812010115","article-title":"Dissecting the fungicidal activity of Calothrix elenkinii using chemical analyses and microscopy","volume":"48","author":"Natarajan","year":"2012","journal-title":"Appl. Biochem Microbiol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0225","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/np980138j","article-title":"Tenuecyclamides A-D, cyclic hexapeptides from the cyanobacterium Nostoc spongiaeforme var tenue","volume":"61","author":"Banker","year":"1998","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0230","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/jo00030a013","article-title":"Calophycin, a fungicidal cyclic decapeptide from the terrestrial blue-green alga Calothrix fusca","volume":"57","author":"Moon","year":"1992","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0235","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1008170007044","article-title":"Allelopathic actions of the alkaloid 12-epi-hapalindole e isonitrile and calothrixin a from cyanobacteria of the genera Fischerella and Calothrix","volume":"12","author":"Doan","year":"2000","journal-title":"J. Appl. Phycol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0240","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1016\/S0040-4039(01)86748-4","article-title":"Hyellazone and chlorohyellazole, two novel carbazoles from the blue-green alga Hyella caespitosa born. et flah","volume":"20","author":"Cardellina","year":"1979","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0245","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/np060324m","article-title":"Carbamidocyclophanes A-E, chlorinated paracyclophanes with cytotoxic and antibiotic activity from the Vietnamese cyanobacterium Nostoc sp","volume":"70","author":"Bui","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1023889813697","article-title":"Fatty acids with antibacterial activity from the cyanobacterium Oscillatoria redekei HUB 051","volume":"15","author":"Mundt","year":"2003","journal-title":"J. Appl. Phycol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0255","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/np9903090","article-title":"Novel extracellular diterpenoids with biological activity from the cyanobacterium Nostoc commune","volume":"63","author":"Jaki","year":"2000","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0260","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/np900661g","article-title":"Crossbyanols A-D, toxic brominated polyphenyl ethers from the Hawai'ian bloom-forming cyanobacterium Leptolyngbya crossbyana","volume":"73","author":"Choi","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0265","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2174\/138945011798109455","article-title":"Chemodiversity in freshwater and terrestrial cyanobacteria \u2212 a source for drug discovery","volume":"12","author":"Chlipala","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2017.04.030_bib0270","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1021\/ja00090a020","article-title":"Total structures of Cryptophycins, potent antitumor depsipeptides from the blue-green alga Nostoc sp. strain GSV 224","volume":"116","author":"Trimurtulu","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2017.04.030_bib0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.6800032","article-title":"Isolation of chlorine-containing antibiotic from the freshwater cyanobacterium Scytonema hofmanni","volume":"215","author":"Mason","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.biopha.2017.04.030_bib0280","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1021\/np100299v","article-title":"Eucapsitrione: an anti-Mycobacterium tuberculosis anthraquinone derivative from the cultured freshwater cyanobacterium Eucapsis sp","volume":"73","author":"Sturdy","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0285","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0944-5013(99)80043-3","article-title":"Inhibitory metabolites production by the cyanobacterium Fischerella muscicola","volume":"153","author":"Srivastava","year":"1999","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.biopha.2017.04.030_bib0290","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/138527208783743750","article-title":"Secondary metabolites from cyanobacteria: complex structure and powerful bioactivities","volume":"12","author":"Gademann","year":"2008","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10811-008-9328-2","article-title":"Isolation and identification of a new antibacterial entity from the Antarctic cyanobacterium Nostoc CCC 537","volume":"21","author":"Asthana","year":"2009","journal-title":"J. Appl. Phycol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10811-005-9011-9","article-title":"Identification of an antimicrobial entity from the cyanobacterium Fischerella sp isolated from bark of Azadirachta indica (Neem) tree","volume":"18","author":"Asthana","year":"2006","journal-title":"J. Appl. Phycol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0305","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/np049671r","article-title":"a glycosylated lipopeptide with antifungal activity from the cyanobacterium Hassallia sp","volume":"68","author":"Neuhof","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0310","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1021\/np0106283","article-title":"Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly","volume":"65","author":"Marquez","year":"2002","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01954842","article-title":"Novel cytotoxic peptides from the tropical marine cyanobacterium Hormothamnion enteromorphoides. 1. Discovery, isolation and initial chemical and biological characterization of the hormothamnins from wild and cultured material","volume":"45","author":"Gerwick","year":"1989","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2017.04.030_bib0320","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/np970146k","article-title":"Kawaguchipeptin B, an antibacterial cyclic undecapeptide from the cyanobacterium Microcystis aeruginosa","volume":"60","author":"Ishida","year":"1997","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0325","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.7164\/antibiotics.45.1458","article-title":"Antifungal cyclic peptides from the terrestrial blue-green alga Anabaena laxa. II. Structures of laxaphycins A, B D and E","volume":"45","author":"Frankm\u00f6lle","year":"1992","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.biopha.2017.04.030_bib0330","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1021\/jo0261909","article-title":"Lobocyclamides A-C lipopeptides from a cryptic cyanobacterial mat containing Lyngbya confervoides","volume":"67","author":"MacMillan","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0335","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/np000133y","article-title":"Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula","volume":"63","author":"Milligan","year":"2000","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0340","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1021\/np8007792","article-title":"Lyngbyazothrins A-D, a ntimicrobial cyclic undecapeptides from the cultured cyanobacterium Lyngbya sp","volume":"72","author":"Zainuddin","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0345","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1021\/np9001674","article-title":"Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms","volume":"72","author":"Simmons","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0350","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/np049596k","article-title":"Majusculoic acid, a brominated cyclopropyl fatty acid from a marine cyanobacterial mat assemblage","volume":"68","author":"MacMillan","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0355","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1016\/S0040-4020(01)00931-0","article-title":"Marine cyanobacteria- a prolifie source of natural products","volume":"57","author":"Burja","year":"2001","journal-title":"Tetrahedron"},{"key":"10.1016\/j.biopha.2017.04.030_bib0360","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/0040-4039(95)00724-Q","article-title":"A new oxazole peptide alkaloid from freshwater cyanobacteria Nostoc muscorum","volume":"36","author":"Nagatsu","year":"1995","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0365","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.micres.2005.08.005","article-title":"Antialgal, antibacterial and antifungal activity of two metabolites produced and excreted by cyanobacteria during growth","volume":"161","author":"Volk","year":"2006","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.biopha.2017.04.030_bib0370","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.phytochem.2007.06.024","article-title":"Insecticidal activity of 12-epi-hapalindole J isonitrile","volume":"68","author":"Becher","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2017.04.030_bib0375","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1389-1723(03)80053-1","article-title":"Bioactivities of nostocine a produced by a freshwater cyanobacterium Nostoc spongiaeforme TISTR 8169","volume":"95","author":"Hirata","year":"2003","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.biopha.2017.04.030_bib0380","series-title":"Biomedical Importance of Marine Organisms","article-title":"New pharmaceuticals from cultured blue-green algae","author":"Moore","year":"1988"},{"key":"10.1016\/j.biopha.2017.04.030_bib0385","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/np0002334","article-title":"a novel antimicrobial cyclophane from the cyanobacterium Nostoc sp","volume":"63","author":"Ploutno","year":"2000","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0390","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00425-004-1307-5","article-title":"Exploitation of marine algae: biogenic compounds for potential antifouling applications","volume":"219","author":"Bhadury","year":"2004","journal-title":"Planta"},{"key":"10.1016\/j.biopha.2017.04.030_bib0395","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1016\/S0040-4039(98)00573-5","article-title":"Nostofungicidine, an antifungal lipopeptide from the field-grown terrestrial blue-green alga Nostoc commune","volume":"39","author":"Kajiyama","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0400","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cca.2004.11.005","article-title":"Pharmacology and toxicology of pahayokolide A, a bioactive metabolite from a freshwater species of Lyngbya isolated from the Florida Everglades, Comp","volume":"139","author":"Berry","year":"2004","journal-title":"Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0405","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/np060389p","article-title":"Structures of pahayokolides A and B, cyclic peptides from a Lyngbya sp","volume":"70","author":"An","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0410","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1021\/np000456u","article-title":"Pitipeptolides A and B, new cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula","volume":"64","author":"Luesch","year":"2001","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0415","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1016\/S0040-4039(00)74436-4","article-title":"Schizotrin A.\u2014 a novel antimicrobial cyclic peptide from a cyanobacterium","volume":"35","author":"Pergament","year":"1994","journal-title":"Tetrahedron. Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0420","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.chembiol.2003.10.001","article-title":"Binding structure of elastase inhibitor scyptolin A","volume":"10","author":"Matern","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0425","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0031-9422(01)00400-9","article-title":"Scyptolin A and B., cyclic desipeptides from axenic cultures of Scytonema hofmanni PCC 7110","volume":"58","author":"Matern","year":"2001","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2017.04.030_bib0430","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1021\/jo00241a033","article-title":"Scytonemin-a, a novel calcium-antagonist from a blue-green-alga","volume":"53","author":"Helms","year":"1988","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0435","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1021\/jo00376a047","article-title":"Scytophycins: cytotoxic and antimitotic agents from the cyanophyte Scytonema pseudohofinanni","volume":"51","author":"Ishibashi","year":"1986","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0440","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1021\/ol050188x","article-title":"Isolation of swinholide A and related glycosylated derivatives from two field collections of marine cyanobacteria","volume":"7","author":"Andrianasolo","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0445","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1021\/np990162c","article-title":"Tanikolide, a toxic and antifungal lactone from the marine cyanobacterium Lyngbya majuscula","volume":"62","author":"Singh","year":"1999","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0450","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1016\/S0040-4020(01)81932-3","article-title":"Tjipanazoles, new antifungal agents from the blue-green alga Tolypothrix tjipanasensis","volume":"47","author":"Bonjouklian","year":"1991","journal-title":"Tetrahedron"},{"key":"10.1016\/j.biopha.2017.04.030_bib0455","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/np049640w","article-title":"Ambigol C and 2 4-dichlorobenzoic acid, natural products produced by the terrestrial cyanobacterium Fischerella ambigua","volume":"68","author":"Wright","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0460","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2006-958092","article-title":"Biological activities of cyanobacteria: evaluation of extracts and pure compounds","volume":"61","author":"Falch","year":"1995","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2017.04.030_bib0465","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1021\/np000297e","article-title":"Two novel cyclic peptides with antifungal activity from the cyanobacterium Tolypothrix byssoidea (EAWAG 195)","volume":"64","author":"Jaki","year":"2001","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0470","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/ja00027a072","article-title":"Tolyporphin: a novel multidrug resistance reversing agent from the blue-green alga Tolypothrix nodosa","volume":"114","author":"Prinsep","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2017.04.030_bib0475","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1351\/pac198658020263","article-title":"Toxins from cyanophytes belonging to the Scytonemataceae","volume":"58","author":"Moore","year":"1986","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0480","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF00249096","article-title":"Biological effects of tolytoxin (6-hydroxy-7-O-methyl-scytophycin b), a potent bioactive metabolite from cyanobacteria","volume":"157","author":"Patterson","year":"1992","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0485","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1351\/pac198254101919","article-title":"Toxin anticancer agents, and tumor promoters from marine prokaryotes","volume":"54","author":"Moore","year":"1982","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0490","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.1021\/ja00101a015","article-title":"Welwitindolinones: unusual alkaloids from the blue-green algae Hapalosiphon welwitschii and Westiella intricate relationship to fischerindoles and hapalinodoles","volume":"116","author":"Stratmann","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2017.04.030_bib0495","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/bit.20912","article-title":"Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate","volume":"94","author":"Yoon","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biopha.2017.04.030_bib0500","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1574-6968.2001.tb10554.x","article-title":"Inhibition of bacterial RNA polymerase by the cyanobacterial metabolites 12-epi-hapalindole E isonitrile and calothrixin A","volume":"196","author":"Doan","year":"2001","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0505","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11418-008-0238-z","article-title":"Two new antibacterial norabietane diterpenoids from cyanobacteria, Microcoleous lacustris","volume":"62","author":"P\u00e9rez-Guti\u00e9rrez","year":"2008","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.biopha.2017.04.030_bib0510","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/aem.62.11.4086-4094.1996","article-title":"Enzymatic pathway for the bacterial degradation of the cyanobacterial cyclic peptide toxin microcystin LR","volume":"62","author":"Bourne","year":"1996","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0515","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.chembiol.2003.10.002","article-title":"New structural insights into the inhibition of serine proteases by cyclic peptides from bacteria","volume":"10","author":"McDonough","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0520","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1016\/j.bmcl.2006.05.094","article-title":"-second antifungal member of the Hassallidin family","volume":"16","author":"Neuhof","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0525","doi-asserted-by":"crossref","first-page":"E1909","DOI":"10.1073\/pnas.1320913111","article-title":"Hassallidins antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway","volume":"111","author":"Vestola","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.04.030_bib0530","first-page":"119","article-title":"Natural products from cyanobacteria: exploiting a new source for drug discovery, I","volume":"9","author":"Sielaff","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2017.04.030_bib0535","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1021\/ja00090a020","article-title":"Total structures of cryptophycins, potent antitumor desipeptides from the blue-green alga Nostoc sp","volume":"116","author":"Golakoti","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2017.04.030_bib0540","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/np0499665","article-title":"Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224","volume":"67","author":"Chaganty","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.04.030_bib0545","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/jo00029a014","article-title":"Ambiguine Isonitriles, Fungicidal Haplindol type alkaloids from three genera of blue-green algae belonging to the Stigonemataceae","volume":"57","author":"Smitka","year":"1992","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0550","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1128\/AAC.49.6.2474-2478.2005","article-title":"Mechanisms of antibacterial action of three monoterpenes","volume":"49","author":"Trombetta","year":"2005","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.biopha.2017.04.030_bib0555","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1016\/0031-9422(91)80077-E","article-title":"Scytophycins from a blue-green alga belonging to the Nostocaceae","volume":"30","author":"Jung","year":"1991","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2017.04.030_bib0560","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.fitote.2006.01.009","article-title":"Activity of blue green microalgae extracts against in vitro generated Staphylococcus aureus with reduced susceptibility to vancomycin","volume":"77","author":"Bhateja","year":"2006","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2017.04.030_bib0565","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1568005024605927","article-title":"The macrolide binding site on the bacterial ribosome","volume":"2","author":"Poehlsgaard","year":"2002","journal-title":"Curr. Drug. Targets Infect. Disord."},{"key":"10.1016\/j.biopha.2017.04.030_bib0570","first-page":"1451","article-title":"Effect of essential oils on pathogenic bacteria","volume":"6","author":"Nazzaro","year":"2013","journal-title":"Pharmaceutical"},{"key":"10.1016\/j.biopha.2017.04.030_bib0575","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.3390\/toxins6113058","article-title":"Chemical compounds toxic to invertebrates isolated from marine cyanobacteria of potential relevance to the agricultural industry","volume":"6","author":"Essack","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.biopha.2017.04.030_bib0580","first-page":"335","article-title":"Combinatorial chemistry: a novel method in drug discovery and its application","volume":"44B","author":"Pandey","year":"2005","journal-title":"Ind. J. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0585","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3389\/fmicb.2016.01899","article-title":"Structural elucidation and molecular docking of a novel antibiotic compound from cyanobacterium Nostoc sp. MGL001","volume":"7","author":"Niveshika","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0590","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/aps.2012.109","article-title":"Computational drug discovery","volume":"33","author":"Ou-Yang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2017.04.030_bib0595","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2017.04.030_bib0600","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cmpb.2015.06.005","article-title":"In silico attempt for adduct agent(s) against malaria: combination of chloroquine with alkaloids of Adhatoda vasica","volume":"122","author":"Swain","year":"2015","journal-title":"Comput. Method. Program. Biomed."},{"key":"10.1016\/j.biopha.2017.04.030_bib0605","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ja.2012.27","article-title":"Thoughts and facts about antibiotics: where we are now and where we are heading","volume":"65","author":"B\u00e9rdy","year":"2012","journal-title":"J. Antibiot."},{"key":"10.1016\/j.biopha.2017.04.030_bib0610","series-title":"Marine Microbiology: Bioactive Compounds and Biotechnologicalapplications","author":"Kim","year":"2013"},{"key":"10.1016\/j.biopha.2017.04.030_bib0615","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4065\/74.6.613","article-title":"The macrolides: erythromycin clarithromycin, and azithromycin, Mayo","volume":"74","author":"Alvarez-Elcoro","year":"1999","journal-title":"Clin. Proc."},{"key":"10.1016\/j.biopha.2017.04.030_bib0620","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0140-6736(97)80051-7","article-title":"Peptide antibiotics","volume":"394","author":"Hancock","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.04.030_bib0625","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/iai.64.12.4922-4927.1996","article-title":"Antiendotoxin activity of cationic peptide antimicrobial agents","volume":"64","author":"Gough","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2017.04.030_bib0630","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1574-6968.2002.tb11000.x","article-title":"Role of membranes in the activities of antimicrobial cationic peptides","volume":"206","author":"Hancock","year":"2002","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/psc.366","article-title":"Peptides as drugs: is there a market?","volume":"8","author":"Loffet","year":"2002","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.biopha.2017.04.030_bib0640","first-page":"499","article-title":"Translating peptides into small molecules","volume":"2","author":"Hummel","year":"2006","journal-title":"Mol. Biol. Syst."},{"key":"10.1016\/j.biopha.2017.04.030_bib0645","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7164\/antibiotics.57.326","article-title":"Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424)","volume":"57","author":"Leadbetter","year":"2004","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.biopha.2017.04.030_bib0650","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1021\/ol048336r","article-title":"Synthesis of novel 6,11-O-bridged bicyclic ketolides via a palladium-catalyzed bis-allylation","volume":"6","author":"Wang","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.biopha.2017.04.030_bib0655","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/AAC.49.1.281-288.2005","article-title":"Binding site of the bridged macrolides in the Escherichia coli ribosome","volume":"49","author":"Xiong","year":"2005","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.biopha.2017.04.030_bib0660","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10637-005-6735-y","article-title":"Phase II trial of dolastatin-10 in patients with advanced breast cancer","volume":"23","author":"Perez","year":"2005","journal-title":"Invest. New Drug"},{"key":"10.1016\/j.biopha.2017.04.030_bib0665","first-page":"85","volume":"11","author":"Anonymous","year":"2011"},{"key":"10.1016\/j.biopha.2017.04.030_bib0670","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/md12010255","article-title":"Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development","volume":"12","author":"Newman","year":"2014","journal-title":"Mar. Drugs"},{"issue":"9","key":"10.1016\/j.biopha.2017.04.030_bib0675","article-title":"Antimycobacterial and cytotoxicity activity of microcystins","volume":"21","author":"Ramos","year":"2015","journal-title":"J. Venom Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.biopha.2017.04.030_bib0680","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.toxicon.2009.07.036","article-title":"Neurotoxic cyanobacterial toxins","volume":"56","author":"Ar\u00e1oz","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biopha.2017.04.030_bib0685","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mrrev.2011.01.002","article-title":"Genotoxicity and potential carcinogenicity of cyanobacterial toxins \u2212 a review","volume":"727","author":"Zegura","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2017.04.030_bib0690","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/toxins5101896","article-title":"Cyanobacteria and cyanotoxins: from impacts on aquatic ecosystems and human health to Anticarcinogenic effects","volume":"5","author":"Zanchett","year":"2013","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.biopha.2017.04.030_bib0695","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.etap.2012.08.005","article-title":"Cylindrospermopsin: waterlinked potentil threat to human health in Europe","volume":"34","author":"Poniedzia\u0142ek","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0700","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.3390\/ijerph8093728","article-title":"Does \u03b1-amino-\u03b2-methylaminopropionic acid (BMAA) play a role in Neurodegeneration?","volume":"8","author":"Chiu","year":"2011","journal-title":"Int J. Environ. Res. Pub. Heal."},{"key":"10.1016\/j.biopha.2017.04.030_bib0705","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5530\/ijper.51.2.36","article-title":"Computational approach for locating effective cyanobacterial compounds against Mycobacterium tuberculosis","volume":"51","author":"Swain","year":"2017","journal-title":"Indian J. Phamaceutical. Educat. Res."},{"key":"10.1016\/j.biopha.2017.04.030_bib0710","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1002\/ejoc.201200657","article-title":"Total synthesis of calothrixins A and B by palladium-catalyzed tandem cyclization\/cross-coupling reaction of indolylborate","volume":"2012","author":"Abe","year":"2012","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.biopha.2017.04.030_bib0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2672.2008.03918.x","article-title":"Applications of cyanobacteria in biotechnology","volume":"106","author":"Abed","year":"2009","journal-title":"J. Appl. Microbiol."},{"issue":"754934","key":"10.1016\/j.biopha.2017.04.030_bib0720","article-title":"Cyanobacteria: photoautotrophic microbial factories for the sustainable synthesis of industrial products","author":"Lau","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2017.04.030_bib0725","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/10408440802291513","article-title":"The molecular genetics and regulation of cyanobacterial peptide hepatotoxin biosynthesis","volume":"38","author":"Pearson","year":"2008","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0730","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-0-387-75865-7_17","article-title":"The genetics and genomics of cyanobacterial toxicity","volume":"619","author":"Neilan","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2017.04.030_bib0735","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/btpr.2358","article-title":"Molecular genetics improvements of cyanobacteria to enhance the industrial potential of the microbe: a review","volume":"32","author":"Johnson","year":"2016","journal-title":"Biotechnol. Prog."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216328979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216328979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T19:15:15Z","timestamp":1719861315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216328979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":147,"alternative-id":["S0753332216328979"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.04.030","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial, antifungal and antimycobacterial compounds from cyanobacteria","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}